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CASE REPORT
Fig. 1. Erythematous grouped papules on wheal-like plaques on
the right cheek.
A Case of Benign Cephalic Histiocytosis
Byung Chul Kim, M.D., Woo Jin Choi, M.D., Na Reu Seung, M.D., Eun Joo Park, M.D., 
Hee Jin Cho, M.D.
1, Kwang Ho Kim, M.D., Kwang Joong Kim, M.D.
Department of Dermatology, College of Medicine, Hallym University, Anyang, 
1Department of Dermatology, College of Medicine, 
Hallym University, Chuncheon, Korea
Benign cephalic histiocytosis (BCH) is a rare non-Langerhans 
cell histiocytosis of unknown etiology. Clinically, lesions are 
characterized by small, red-to-yellow papules distributed 
mainly on the head, face, neck, and shoulders of infants and 
children. Histopathological specimens show massive his-
tiocytic infiltration of the superficial dermis. Immunohis-
tochemically, they are positive for CD68, but negative for 
CD1a and S-100. Two cases have been reported so far in the 
relevant work published in Korean literature. Herein, we 
report on an additional case of BCH. (Ann Dermatol 23(S1) 
S16∼S19, 2011)
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INTRODUCTION
Benign cephalic histiocytosis (BCH) is a rare, non-Langer-
hans histiocytosis first described by Gianotti et al
1. in 
1971. It is characterized by asymptomatic eruptions of 
slightly raised, round or oval, orange-red, or red-brown 
papules distributed mainly on the head, face, neck, and 
shoulders of infants and young children, which shows 
spontaneous regression with time. The histopathological 
features show a well-circumscribed histiocytic infiltrate 
within the superficial to mid-reticular dermis. The histio-
cytes express CD68 and HAM56, but are characteristically 
S-100 and CD1a negative.
It is a rare disease in infants and only 2 cases have been 
reported so far in the Korean language published work
2,3. 
We recently had the opportunity to observe a case of BCH 
that had developed on the right cheek.
CASE REPORT
A 7-month-old boy visited our clinic with the complaint of 
small papules and plaques on his right cheek since the age 
of 4 months. He had no significant medical history and 
had normally reached all of his developmental milestones. 
On physical examination, erythematous grouped papules 
on wheal-like plaques were observed on the right cheek, 
as shown in Fig. 1. The laboratory work-up revealed the 
following: WBC, 125,000/mm
3; neutrophil, 25.3% (40∼
74%); eosinophil, 9.5% (0∼7%); and aspartate amino-
transferase (AST), 52 IU/L. Results of other laboratory work- 
ups were normal.A Case of Benign Cephalic Histiocytosis
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Fig. 2. (A) Diffuse cell infiltrates were observed throughout the dermis (H&E, ×100). (B) High power view demonstrating proliferation
of large, epithelioid histiocytic cells with eosinophilic cytoplasm (H&E, ×400).
Fig. 3. Immunohistochemical staining shows (A) positive for CD68 (×400), negative for (B) S-100 and (C) CD1a (×400).
A biopsy specimen of the upper lesion of a wheal-like 
plaque showed a spread that infiltrated the entire dermis, 
with no epidermotropism (Fig. 2A). Most of the cells within 
the infiltrates were large, epithelioid histiocytic cells with 
eosinophilic cytoplasm (Fig. 2B). Lymphocytes and eosino-
phils were scattered among the histiocytes. Immunohistoc-
hemistry showed positive staining for CD68 in lesional cells 
(Fig. 3A), but negative for S-100 protein or CD1a (Fig. 3B, 
C). Based on these clinical and histological features, we 
diagnosed this disorder as a benign cephalic histiocytosis. 
In view of the self-healing nature of the illness, we only 
observed the patient, without administering any medica-
tion. The papules and plaques have gradually become flat 
and have shown regression for 11 months, leaving brown- 
pigmented lesions.
DISCUSSION
BCH is a rare non-Langerhans cell histiocytic childhood 
disorder that presents as a self-healing eruption. The 
eruption usually starts during the first 3 years of life. Its 
clinical manifestations are small, red-to-yellow papules 
distributed mainly on the head, face, neck, and shoulders, 
although it may become generalized. Cases involving 
fused papules and formation of reticulated patterns have 
also been reported
3,4. The case discussed in this report BC Kim, et al
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displayed clinical characteristics of BCH with papules and 
plaques on the right cheek. Typically, there is no mucous 
membrane, acral, or visceral involvement. Spontaneous 
regression of the eruption is the rule; complete regression 
occurs within 50 months, on average. However, recent 
studies have suggested an association of BCH with other 
non-Langerhans cell histiocytosis disorders, and BCH is 
now regarded as a part of non-Langerhans cell histiocy-
tosis in its clinical spectrum
5-8. In general, BCH does not 
lead to abnormalities in laboratory test results, or have 
known complications. However, diabetes inspidus and 
insulin-dependent diabetes mellitus have been reported in 
association with BCH from infiltration of the pituitary 
stalk, which has been described more commonly in 
Langerhans cell histiocytosis and xanthoma dissemina-
tum
9,10.
The histopathologic hallmark of BCH is a well-circum-
scribed histiocytic infiltration of the superficial to mid- 
reticular dermis with attenuation of the adjacent epidermis 
and flattened rete ridges. Epidermotropism is not a feature, 
and there is a mixed inflammatory infiltrate composed of 
lymphocytes and rare eosinophils. Histiocytes are typically 
large, with abundant eosinophilic cytoplasm and oval, 
hyperchromic, or vesicular nuclei, often with very promi-
nent nucleoli. Older lesions may contain giant cells, and 
mitoses are absent. Immunohistochemically, Langerhans cell 
markers, CD1a and S-100 protein antibodies, are negative, 
whereas macrophage/ histiocytic markers, CD68 and factor 
XIIIa, are positive. Histiocytes that had infiltrated the dermis 
were observed in the histological findings of the case. 
Results of immunohistochemical staining were negative for 
CD1a and S-100 and positive for CD68, indicating that 
BCH belongs within a spectrum of non-Langerhans cell 
histiocytosis.
Clinical and/or histological differential diagnosis includes 
the micronodular form of juvenile xanthogranuloma (JXG), 
Langerhans cell histiocytosis (LCH), and generalized erup-
tive histiocytosis (GEH)
3,5,11. The micronodular form of JXG 
presents more disseminated eruptions than BCH usually 
does, and there can be ocular involvement. Histology 
shows lipid accumulation within histiocytic cells, abun-
dant foamy cells, and Touton giant cells. GEH is micro-
scopically very similar to BCH, but typically affects adults 
with more extensive distribution of lesions, and occasional 
mucosal lesions. LCH preferentially affects flexor surfaces 
with a more florid, scaling, and crusting papular eruption. 
One or more visceral organs may be involved, and there 
may be associated fever, malaise, and failure to thrive. 
Immunohistochemically, LCH differs from BCH in positive 
staining for CD1a and S-100, and negative staining for 
CD68 and factor XIIIa. The cases were diagnosed as BCH, 
based on skin lesions and their distribution characteristics, 
absence of an association with systemic diseases, conditions 
that regressed with elapsed time, histological findings that 
displayed proliferation of histiocytes in the dermis, and 
immunohistochemical staining findings that indicated 
traits of non-Langerhans cell histiocytosis [CD1a/S-100 (−/
−), CD68(＋)].
Etiology of BCH is unclear; however, there is evidence to 
support the hypothesis that BCH, GEH, and JXG are part 
of an overlapping clinical spectrum of disease. Transfor-
mation of BCH lesions into JXG has been reported in 2 
infants, aged 6 months
6 and 1 year
7, respectively. In 
addition, Sidwell et al. reported a case of simultaneous 
occurrence of disseminated JXG and BCH
8. These findings 
can be interpreted as being supportive of the hypothesis 
that BCH and JXG are different morphologic expressions 
of the same disease. BCH, GEH, and the mononuclear 
JXG share a common histiocytic cell phenotype, notably 
the vacuolated histiocyte. The fact that the three disorders 
cannot be differentiated solely based on a histological 
study also supports such a hypothesis
12.
BCH is a self-limiting disorder that shows improvement 
within several months or years. Thus, distinguishing it 
from other diseases is important for an accurate diagnosis, 
and the nature of BCH should be explained to the patient 
and the family. Although no cases of BCH in association 
with systemic diseases have been reported, rare cases of 
diabetes inspidus or insulin-dependent diabetes mellitus 
in BCH patients, as well as transitions to other non- 
Langerhans cell histiocytosis disorders, have been reported. 
Therefore, periodic monitoring of patients’ progress would 
be advisable.
A small number of cases of BCH have been reported 
worldwide in published English-language studies
5,12,13, 
and only two cases have been reported in Korean 
literature
2,3; therefore, we decided to share our diagnosis 
of BCH.
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